Litcius/Paper detail

PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19

Mohammad Rafi Khezri

2021Human Cell49 citationsDOIOpen Access PDF

Topics & Concepts

PI3K/AKT/mTOR pathwayCoronavirus disease 2019 (COVID-19)Protein kinase BMedicine2019-20 coronavirus outbreakAdjuvant therapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Signal transductionAdjuvantCancer researchOncologyVirologyInternal medicineBiologyCell biologyCancerOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesRespiratory Support and MechanismsCancer, Stress, Anesthesia, and Immune Response
PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19 | Litcius